Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017237
Filing Date
2025-06-13
Accepted
2025-06-13 17:00:26
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 form4-06132025_050621.html 4  
1 form4-06132025_050621.xml 4 4264
  Complete submission text file 0001415889-25-017237.txt   5673
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
CLARK IAN T (Reporting) CIK: 0001336504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 251047505

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)